KA Imaging’s Reveal 35C Shown to Find More Pneumonia Cases than Traditional X-Ray

Data drives decisions and with the latest trial data, we are positioned for growth,” says Amol Karnick, President and CEO of KA Imaging. In a paper presented earlier this year, the Reveal 35C technology was shown to detect 25% more pneumonia cases (including COVID-19) than traditional X-Ray1.

Reveal 35C is the world’s first single exposure portable dual-energy X-ray detector. Reveal is retrofittable and can be called a detector-side dual-energy upgrade: simply by replacing the detector, any existing X-ray system can be upgraded to dual-energy. With the same radiation dose as a chest X-ray, it creates 3 images without motion artifacts (standard digital X-ray, soft tissue and bone), giving the ability to see the lungs and soft tissue without having bones obstructing the view.

The paper presents the initial results of an ongoing clinical trial that is being carried out in Toronto (Canada). “Although Reveal has been available for sale in both the US and Canada for the past year, we have enrolled Reveal in a number of clinical trials to demonstrate the significant improvement in clinical outcomes compared to standard digital X-ray,” says Karnick.

According to the company, Reveal 35C enhances the use of dual energy, benefiting not only radiologists, but the entire service chain.

“It’s good for radiologists, who can access supplementary dual energy X-ray images for faster and easier reading,” explains Karnick. “It’s good for imaging technologists, who can offer patients more comfort by bringing the detector to the point of care and getting high-quality images even in challenging settings such as critical care units; it’s good for administrators, who can optimize the use of other equipment across multiple departments; and it is especially good for patients, who have more comfort and early access to treatment for diseases that could go unnoticed until they become more serious”, he concludes.


  1. Sanchez F, Kandel S, May M, Ronghe S, Rogalla P. Diagnostic value of dual-energy chest x-ray in immunocompromised patients to rule out pneumonia: initial results. European Congress of Radiology-ECR 2021, 2021.

 

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.